Hot topic: Anatomy of a crisis

Scientific challenges in bringing Covid 19 to a halt in Denmark

7. Sep 2021

1 session course

Danish

900 DKK ex VAT
(app. 121 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Drug monitoring and side effect management have become dinner party conversation topics at parties around the world. The attention forces experts to be brief, and the consequence is loss of details.

This morning, we give the experts time to explain, when we shed light on the side effects of Corona vaccines from a pharmacoepidemiological, pharmacovigilance, biological, medical and regulatory point of view.

We have gathered some of the most important experts in the COVID-19 field. They share their professional considerations and the studies that underlie recent decisions related to the rollout of Corona vaccines.


Hi! Do you need help choosing the right course?

We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com


Get detailed insights and take part in a professional discussion of recent crisis management. You also have the opportunity to ask your pressing questions – for example:

  • How do you find the balance between benefit and harm?
  • What happens to professionalism when many and quick decisions must be made on limited knowledge?
  • How to get a true and fair view of side effects based on spontaneous reports?
  • Will the Danish-Norwegian registry study change drug monitoring in the Nordic region going forward?

We have a limited number of physical seats at this seminar, so sign up today.


KEY WORDS

  • COVID-19
  • Pharmacovigilance
  • Vaccines
  • Side effects
  • Real World Evidence
Read more

Course leader(s) & Lecturers

  • Jesper Hallas
    Course leader
    Professor in Clinical Pharmacology
    Univerisity of Copenhagen
  • Anton Pottegård
    Lecturer
    Professor
    Syddansk Universitet
  • Anne Mette Hvas
    Lecturer
    Professor
    Aarhus universitet
  • Søren Brostrøm
    Lecturer
    Direktør
    Sundhedsstyrelsen
See all

IS THIS hot topic FOR YOU?

If you work with monitoring drugs or dealing with side effects, this is a unique opportunity for insight into a fresh case of dealing with all phases of the process from the first suspicion to a regulatory decision. You will also find the seminar relevant if you are interested in the specific use of RWE in the registration of side effects.

What you will learn

  1. Insight into the overall pharmacovigilance process from the earliest signal to the regulatory decision
  2. A demonstration of options for actions during a crisis
  3. In-depth knowledge of results and considerations from a Danish-Norwegian register study
  4. Examples of how quickly and efficiently things can change, when we collaborate across professional groups and countries

What your company will get

  1. An employee who understands the importance of contextual considerations when assessing results from drug monitoration
  2. An employee who knows the professional considerations behind the decisions made on the roll-out of Corona vaccines in Denmark

Calendar

7. Sep 2021 9:00-11:30
  • Welcome Professor Jesper Hallas, University of Southern Denmark
  • From a pharmacoepidemiological and pharmacovigilance point of view: How great are the risks are we talking about?
  • Danish-Norwegian registry study on side effects of Corona vaccine
  • Review of study results, interpretation and reservations.
  • Lessons learned
Professor Anton Pottegård, University of Southern Denmark
  • From a biological and medical point of view: What disease characteristics do we experience and how can it be handled in the clinic?
  • Clinical spectrum
  • What are the biological mechanisms behind vaccine-related syndrome (WHITE)?
  • Diagnostic challenges
  • How should manifest VITT be handled clinically?

Professor Anne Mette Hvas, Aarhus University

  • From a regulatory point of view: What consequences should one take?
  • Public health perspectives in the rollout of mass vaccination: Balance between benefit and harm
  • Authority decisions under limited knowledge: inclusion of professional advice
  • Communication, transparency and trust
Director Søren Brostrøm, Danish Health Authorities.
  • Panel discussion
Practical information

Registration

Registration deadline
7. Sep 2021
Atrium
Lersø Parkallé 101
2100 København Ø
Sometimes things change. This is the expected programme.

Course leader(s)

Jesper Hallas
Professor in Clinical Pharmacology
Univerisity of Copenhagen

Lecturers

Anton Pottegård
Professor
Syddansk Universitet
Anne Mette Hvas
Professor
Aarhus universitet
Søren Brostrøm
Direktør
Sundhedsstyrelsen

You may also be interested in these courses

Want to know more, or need help?

Contact Client Manager Ida Salicath at +45 39 15 09 46

Send me a message